BMI-Adjusted PEEP During One-Lung Ventilation in Thoracic Surgery (SIMPLE-PEEP)
Effect of Body Mass Index-Adjusted Positive End-Expiratory Pressure on Respiratory Mechanics During One-Lung Ventilation in Thoracic Surgery
One-lung ventilation (OLV) is required during many thoracic surgical procedures and is associated with reduced functional residual capacity, atelectasis, ventilation-perfusion mismatch, hypoxemia, and potentially ventilator-induced lung injury. Lung-protective ventilation strategies include low tidal volumes, limitation of airway pressures, and positive end-expiratory pressure (PEEP), but the optimal PEEP level during OLV remains uncertain. Fixed PEEP is simple and reproducible but does not account for individual patient characteristics. Body mass index (BMI) is readily available before anesthesia and is associated with respiratory mechanics, making it a pragmatic candidate for simple PEEP individualization.
SIMPLE-PEEP is a prospective, multicenter, pragmatic, open-label, randomized clinical trial including 150 adults undergoing elective pulmonary resection under general anesthesia requiring OLV. Participants will be randomized to either fixed PEEP of 4 cmH2O or BMI-adjusted PEEP calculated as BMI/3 cmH2O. Other key components of lung-protective ventilation will be standardized between groups.
The primary outcome is driving pressure during the first 20 minutes of OLV, assessed at 5, 10, and 20 minutes after OLV initiation. Secondary outcomes include respiratory system compliance and other respiratory mechanics, estimated mechanical power, oxygenation, intraoperative hypoxemia and rescue maneuvers, hemodynamic safety, vasopressor requirements, and exploratory postoperative respiratory outcomes. No investigational medicinal product, additional invasive procedure, or study-specific advanced monitoring is required.
Studieoversikt
Status
Intervensjon / Behandling
Studietype
Registrering (Antatt)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiekontakt
- Navn: Jesús M Nieves Alonso, MD
- Telefonnummer: +34915202540
- E-post: jesusmna@gmail.com
Studiesteder
-
-
Catalonia
-
Barcelona, Catalonia, Spania, 08036
- Har ikke rekruttert ennå
- Hospital Clinic Barcelona
-
Ta kontakt med:
- Manuel L López
- E-post: LOPEZ10@clinic.cat
-
Barcelona, Catalonia, Spania, 08041
- Har ikke rekruttert ennå
- Hospital de la Santa Creu i Sant Pau
-
Ta kontakt med:
- Ana P Parera
- E-post: AParera@santpau.cat
-
-
Madrid
-
Madrid, Madrid, Spania, 28006
- Rekruttering
- Hospital Universitario de La Princesa
-
Ta kontakt med:
- Jesús M Nieves Alonso, MD
- Telefonnummer: +34915202540
- E-post: jesusmna@gmail.com
-
Madrid, Madrid, Spania, 28007
- Har ikke rekruttert ennå
- Hospital General Universitario Geogorio Marañón
-
Ta kontakt med:
- Estrela C Caamaño
- E-post: estrelacaamano@gmail.com
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- Age 18 years or older.
- Scheduled thoracic surgery for pulmonary resection requiring general anesthesia and one-lung ventilation.
- Written informed consent obtained before any study-specific procedure.
Exclusion Criteria:
- Simultaneous participation in another interventional clinical trial that could interfere with the protocol.
- Severe hemodynamic instability before the start of the procedure, defined as continuous vasopressor infusion or shock of any etiology.
- Severe restrictive lung disease, defined as total lung capacity <50% of predicted or forced vital capacity <50% of predicted.
- Body mass index >45 kg/m2.
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Støttende omsorg
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Aktiv komparator: Fixed PEEP of 4 cmH2O
|
Fixed PEEP of 4 cmH2O |
|
Eksperimentell: BMI-adjusted PEEP calculated as BMI/3 cmH2O
|
BMI-adjusted PEEP calculated as BMI/3 cmH2O |
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Driving pressure during the primary T2-T4 window
Tidsramme: 20 minutes
|
Driving pressure during the primary T2-T4 window, measured at 5, 10, and 20 minutes after initiation of one-lung ventilation and expressed in cmH2O. In conventional volume-controlled ventilation, driving pressure is calculated as plateau pressure minus applied PEEP. In pressure-regulated volume-targeted/volume-guaranteed modes, driving pressure is calculated as total end-inspiratory pressure minus applied PEEP. |
20 minutes
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Respiratory system compliance
Tidsramme: At 5, 10, and 20 minutes after initiation of one-lung ventilation; at 60 minutes when applicable; and at the end of one-lung ventilation, all during the surgical procedure on Day 1.
|
Respiratory system compliance will be calculated at each applicable time point as tidal volume divided by driving pressure and expressed in mL/cmH2O |
At 5, 10, and 20 minutes after initiation of one-lung ventilation; at 60 minutes when applicable; and at the end of one-lung ventilation, all during the surgical procedure on Day 1.
|
|
Driving pressure at 60 minutes and at the end of one-lung ventilation
Tidsramme: At 60 minutes after initiation of one-lung ventilation, when applicable, and at the end of one-lung ventilation.
|
Driving pressure will be assessed at 60 minutes after initiation of one-lung ventilation, when this time point is applicable, and at the actual end of one-lung ventilation, to evaluate the persistence of the physiological effect of the assigned PEEP strategy. |
At 60 minutes after initiation of one-lung ventilation, when applicable, and at the end of one-lung ventilation.
|
|
Estimated mechanical power during one-lung ventilation
Tidsramme: At 5, 10, and 20 minutes after initiation of one-lung ventilation; at 60 minutes when applicable; and at the end of one-lung ventilation, all during the surgical procedure on Day 1.
|
Ventilatory mechanical power will be estimated from prospectively recorded ventilatory parameters using a prespecified calculation method appropriate to the ventilation mode and expressed in J/min. |
At 5, 10, and 20 minutes after initiation of one-lung ventilation; at 60 minutes when applicable; and at the end of one-lung ventilation, all during the surgical procedure on Day 1.
|
|
Incidence of intraoperative hypoxemia during one-lung ventilation
Tidsramme: From initiation until completion of one-lung ventilation during the surgical procedure on Day 1 (up to 1 day).
|
Intraoperative hypoxemia will be defined as SpO2 <90% sustained for at least 60 seconds during one-lung ventilation with baseline FiO2 0.6, or any episode of SpO2 <90% requiring immediate clinical intervention at the discretion of the attending anesthesiologist. |
From initiation until completion of one-lung ventilation during the surgical procedure on Day 1 (up to 1 day).
|
|
Incidence of major ventilatory rescue
Tidsramme: During the first 20 minutes after initiation of one-lung ventilation on Day 1.
|
Major ventilatory rescue during the first 20 minutes after initiation of one-lung ventilation will be defined as any intervention that substantially modifies the assigned ventilatory strategy or respiratory mechanics, including modification of PEEP from the assigned value, recruitment maneuver, CPAP to the non-ventilated lung, temporary restoration of two-lung ventilation, or protocol interruption for safety reasons. |
During the first 20 minutes after initiation of one-lung ventilation on Day 1.
|
|
Incidence of intraoperative hypotension
Tidsramme: Intraoperative/periprocedural period on Day 1, from induction of anesthesia until the end of surgery.
|
Intraoperative hypotension will be defined as mean arterial pressure <65 mmHg sustained for more than 1 minute. |
Intraoperative/periprocedural period on Day 1, from induction of anesthesia until the end of surgery.
|
|
Requirement for intraoperative vasopressor support
Tidsramme: Time Frame: Intraoperative/periprocedural period on Day 1, from induction of anesthesia until the end of surgery.
|
Proportion of participants requiring vasopressor administration during the intraoperative period. Vasopressor use will be recorded as a measure of the hemodynamic safety of the assigned PEEP strategy. |
Time Frame: Intraoperative/periprocedural period on Day 1, from induction of anesthesia until the end of surgery.
|
|
Incidence of postoperative pulmonary complications
Tidsramme: From the end of surgery until hospital discharge during the index hospitalization (estimated average duration: 3-10 days).
|
Occurrence of at least one prespecified postoperative pulmonary complication, including acute respiratory failure, pneumonia, acute respiratory distress syndrome, atelectasis, pneumothorax, bronchopleural fistula, aspiration pneumonitis, pulmonary embolism, pleural empyema, bronchospasm, pleural effusion, or need for postoperative respiratory support or reintubation for respiratory deterioration. This outcome will be considered exploratory. |
From the end of surgery until hospital discharge during the index hospitalization (estimated average duration: 3-10 days).
|
Samarbeidspartnere og etterforskere
Sponsor
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Antatt)
Studiet fullført (Antatt)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- SIMPLE-PEEP
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .